MedTrace Logo

Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)

NCT01436253 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2196

Last updated 2022-02-09

Study results available
· View outcomes & findings →

Summary

This study is being done to see whether dietary and medicinal measures compliant with hyperlipidemia treatment guidelines will result in achieving target lipid values and to evaluate the total risk of cardiovascular disease in study participants who have not reached satisfactory lipid levels with their current hypolipemic therapy.

Conditions

Interventions

BEHAVIORAL

Lifestyle Changes

Diet, increased physical activity, and weight reduction as per European Guidelines on the Management of Hypercholesterolemia accepted by the Croatian Society of Cardiology were encouraged in addition to pharmacological measures at the discretion of the treating physician.

DRUG

Hypolipemics

Pharmacological measures at the discretion of the treating physician and in accordance with the respective authorized label and European Guidelines on the Management of Hypercholesterolemia accepted by the Croatian Society of Cardiology.

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2013-02-28
Completion
2013-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01436253 on ClinicalTrials.gov